Effective October 13, 2023, John Cassels is being replaced as the Chief Financial Officer (?CFO?) of CannPharmaRX, Inc. effective June 1, 2023. There was no disagreement between and Mr. Cassels on any matter related to operations, policies or practices that led to Mr. Cassels?s replacement as CFO. Effective October 13, 2023, Board of Directors has determined to appoint Oliver Foeste as Chief Financial Officer.

Mr. Foeste has consented to such appointment. Mr. Foeste is the founder and Managing Partner of Invictus Accounting Group LLP and has significant executive, director, finance, and public company compliance experience across a number of industry sectors including cannabis and nutraceuticals. Prior to Invictus, Mr. Foeste was in senior finance and accounting roles at TSX, TSXV, and NYSE listed issuers, and earned his CPA at Deloitte and a boutique tax advisory firm.